Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001493152-25-020601·J. WOOD CAPITAL ADVISORS LLC
Schedule 13G ownership disclosure
Karyopharm Therapeutics Inc
Common Stock, $0.0001 par value · CUSIP: 48576U205
Event date: 2025-10-14
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- J. Wood Capital Advisors LLC
Shares: 1,000,708.00 · Class: 4.99%
- Jason Wood
Shares: 1,000,708.00 · Class: 4.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-020601
- Form type
- SCHEDULE 13G/A
- Filer
- J. WOOD CAPITAL ADVISORS LLC
- CIK
- CIK 1586446
- Filed
- Nov 03, 2025
- Reporting period
- Oct 14, 2025
- Description
- Schedule 13G beneficial ownership